Table 4.

Clinical and genomic characteristics of study population according to subsequent SubRT, ROBO1, and KAT2B somatic mutation status.

Characteristic	No SubRT+mutated (n = 2)	SubRT +nonmutated (n = 6)	No SubRT+nonmutated (n = 10)	P value
AGE (mean ± SD)	65.5 ± 16.3	70.3 ± 6.6	65.5 ± 6.9	0.500
SEX (male)	1 (50.0%)	5 (83.3%)	2 (20.0%)	0.027
ROBO1	2 (100.0%)	0 (0.0%)	0 (0.0%)	0.007
KAT2B	2 (100.0%)	0 (0.0%)	0 (0.0%)	0.007
APBA1	1 (50.0%)	0 (0.0%)	1 (10.0%)	0.314
GNA13	1 (50.0%)	1 (16.7%)	0 (0.0%)	0.085
MYD88	2 (100.0%)	1 (16.7%)	3 (30.0%)	0.193
SETD1B	1 (50.0%)	0 (0.0%)	1 (10.0%)	0.314
IniRT	0 (0.0%)	0 (0.0%)	2 (20.0%)	0.608
IniST	1 (50.0%)	6 (100.0%)	6 (60.0%)	0.212
SubRT	0 (0.0%)	6 (100.0%)	0 (0.0%)	<0.001
SubST	0 (0.0%)	2 (33.3%)	1 (10.0%)	0.669
OS	1 (50.0%)	6 (100.0%)	9 (90.0%)	0.314

P value is estimated using the Wilcoxon rank-sum test or Fisher's exact test.